CLFD Stock Analysis: Clearfield | NASDAQ
Communication Equipment | NASDAQ, USA | Market Cap: 475m USD | 12M Return: -24.1% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 7.97M
Qual. Beats: 0
Rev. Trend: -87.5%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Clearfield, Inc. (NASDAQ: CLFD) designs, manufactures, and distributes fiber management, protection, and delivery products, serving U.S. and international markets. Its product portfolio includes the FieldSmart line of panels, cabinets, and enclosures; WaveSmart optical components; FiberFlex outdoor active cabinets; CraftSmart pedestals; YOURx access terminals; FieldShield fiber pathway solutions; and pre-terminated fiber assemblies, among others. The company sells to national carriers, community broadband providers, multiple system operators, large enterprises, and OEM customers through its direct sales force and authorized distributors. Originally incorporated in 1979 as APA Enterprises, Clearfield adopted its current name in January 2008 and is headquartered in Minneapolis, Minnesota.
As a small-cap player in the Communications Equipment sub-industry, Clearfield operates within the broadband infrastructure segment, providing the physical-layer hardware that enables fiber-to-the-premises (FTTP), fiber-to-the-business, and small cell/backhaul deployments. Its business model is product-driven rather than service-based, with revenue generated through unit sales of standardized and customized fiber optic assemblies and enclosures to telecom operators and enterprise network builders.
- BEAD federal broadband funding accelerates rural fiber deployment demand
- Community broadband and FTTH buildouts drive core product revenue
- Customer inventory normalization pressures near-term fiber product shipments
| Net Income: -8.61m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.34 > 1.0 |
| NWC/Revenue: 110.3% < 20% (prev 98.63%; Δ 11.71% < -1%) |
| CFO/TA 0.07 > 3% & CFO 18.1m > Net Income -8.61m |
| Net Debt (-80.1m) to EBITDA (13.9m): -5.75 < 3 |
| Current Ratio: 12.84 > 1.5 & < 3 |
| Outstanding Shares: last quarter (13.7m) vs 12m ago -3.01% < -2% |
| Gross Margin: 37.23% > 18% (prev 24.54%; Δ 12.69% > 0.5%) |
| Asset Turnover: 47.43% > 50% (prev 57.33%; Δ -9.90% > 0%) |
| Interest Coverage Ratio: 78.68 > 6 (EBIT TTM 8.34m / Interest Expense TTM 106k) |
| A: 0.57 (Total Current Assets 163.0m - Total Current Liabilities 12.7m) / Total Assets 263.5m |
| B: 0.40 (Retained Earnings 105.8m / Total Assets 263.5m) |
| C: 0.03 (EBIT TTM 8.34m / Avg Total Assets 287.2m) |
| D: 11.71 (Book Value of Equity 242.8m / Total Liabilities 20.7m) |
| Altman-Z'' = 17.54 = AAA |
| DSRI: 1.13 (Receivables 20.9m/24.2m, Revenue 136.2m/178.2m) |
| GMI: 0.66 (GM 24.54% / 37.23%) |
| AQI: 1.54 (AQ_t 0.31 / AQ_t-1 0.20) |
| SGI: 0.76 (Revenue 136.2m / 178.2m) |
| TATA: -0.10 (NI -8.61m - CFO 18.1m) / TA 263.5m) |
| Beneish M = -3.09 (Cap -4..+1) = AA |
As of July 09, 2026, the stock is trading at USD 32.94 with a total of 120,347 shares traded. Over the past week, the price has changed by -17.22%, over one month by -19.85%, over three months by +23.97% and over the past year by -24.07%.
Current recommended Stop Loss: 28.20 (which is 14.4% or 1.7 ATR below the current price).
Clearfield has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy CLFD.
- StrongBuy: 2
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 43.8 | 32.8% |
P/E Trailing = 152.0
P/E Forward = 20.5761
P/S = 3.1982
P/B = 1.9012
Revenue TTM = 136.2m USD
EBIT TTM = 8.34m USD
EBITDA TTM = 13.9m USD
Long Term Debt = 8.05m USD (estimated: total debt 10.9m - short term 2.89m)
Short Term Debt = 2.89m USD (from shortTermDebt, last quarter)
Debt = 10.9m USD (from shortLongTermDebtTotal, last quarter) (leases 10.9m already included)
Net Debt = -80.1m USD (calculated: Debt 10.9m - CCE 91.1m)
Enterprise Value = 395.0m USD (475.1m + Debt 10.9m - CCE 91.1m)
Interest Coverage Ratio = 78.68 (Ebit TTM 8.34m / Interest Expense TTM 106k)
EV/FCF = 24.54x (Enterprise Value 395.0m / FCF TTM 16.1m)
FCF Yield = 4.07% (FCF TTM 16.1m / Enterprise Value 395.0m)
FCF Margin = 11.81% (FCF TTM 16.1m / Revenue TTM 136.2m)
Net Margin = -6.32% (Net Income TTM -8.61m / Revenue TTM 136.2m)
Gross Margin = 37.23% ((Revenue TTM 136.2m - Cost of Revenue TTM 85.5m) / Revenue TTM)
Gross Margin QoQ = 32.45% (prev 33.16%)
Tobins Q-Ratio = 1.50 (Enterprise Value 395.0m / Total Assets 263.5m)
Interest Expense / Debt = 0.97% (Interest Expense 106k / Debt 10.9m)
Taxrate = 26.12% (2.15m / 8.23m)
NOPAT = 6.16m (EBIT 8.34m * (1 - 26.12%))
Current Ratio = 12.84 (Total Current Assets 163.0m / Total Current Liabilities 12.7m)
Debt / Equity = 0.05 (Debt 10.9m / totalStockholderEquity, last quarter 242.8m)
Debt / EBITDA = -5.75 (Net Debt -80.1m / EBITDA 13.9m)
Debt / FCF = -4.98 (Net Debt -80.1m / FCF TTM 16.1m)
Total Stockholder Equity = 253.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -3.00% (Net Income -8.61m / Total Assets 263.5m)
RoE = -3.40% (Net Income TTM -8.61m / Total Stockholder Equity 253.3m)
RoCE = 3.19% (EBIT 8.34m / Capital Employed (Equity 253.3m + L.T.Debt 8.05m))
RoIC = 2.50% (NOPAT 6.16m / Invested Capital 246.9m)
WACC = 12.33% (E(475.1m)/V(486.0m) * Re(12.60%) + D(10.9m)/V(486.0m) * Rd(0.97%) * (1-Tc(0.26)))
Discount Rate = 12.60% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -91.11 | Cagr: -4.64%
[DCF] Terminal Value 60.86% ; FCFF base≈16.8m ; Y1≈15.4m ; Y5≈13.7m
[DCF] Fair Price = 15.53 (EV 130.9m - Net Debt -80.1m = Equity 211.0m / Shares 13.6m; r=12.33% [WACC]; 5y FCF grow -10.22% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.08 | # QB: 0
Revenue Correlation: -87.52 | Revenue CAGR: -21.16% | SUE: 0.06 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.24 | Chg30d=+4.26% | Revisions=-25% | Analysts=2
EPS current Year (2026-09-30): EPS=0.70 | Chg30d=+0.00% | Revisions=+25% | GrowthEPS=+55.6% | GrowthRev=+9.9%
EPS next Year (2027-09-30): EPS=1.45 | Chg30d=-17.14% | Revisions=+25% | GrowthEPS=+107.1% | GrowthRev=+21.5%
[Analyst] Revisions Ratio: +17% (up=2, down=1)